FDA foreign inspection program "next area of reform," Sen. Mikulski predicts.
This article was originally published in The Tan Sheet
Executive Summary
FDA FOREIGN INSPECTION PROGRAM "NEXT AREA OF REFORM," SEN. MIKULSKI predicted in an address to the Pharmaceutical Research & Manufacturers of America annual meeting in White Sulphur Springs, W.Va. May 11. "I am deeply troubled...that so much [raw material] is coming now from India and China with very poor regulation and very poor oversight," Barbara Mikulski (D-Md.) said. "I'm afraid that there are dangerous situations waiting to happen and it will affect every single one of us," she added. "Let us put our thinking cap on about how we can create a regulatory framework and how to be able to fund it."